VERMILLION, INC. Uncategorized Contracts & Agreements
47 Contracts & Agreements
- At The Market Offering Agreement between Aspira Womens Health Inc. and H.C. Wainwright & Co., LLC dated August 2, 2024 (Filed With SEC on August 2, 2024)
- Description of Aspira Women's Health Inc.'s Securities Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on April 1, 2024)
- Description of Aspira Women's Health Inc.'s Securities Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 31, 2022)
- Description of Aspira Women's Health Inc.'s Securities Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 31, 2021)
- Description of Vermillion, Inc.s Securities Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on April 7, 2020)
- Exhibit 10.2 (Filed With SEC on December 20, 2017)
- Exhibit 10.1 (Filed With SEC on December 20, 2017)
- VERMILLION, INC. 12117 BEE CAVES ROAD, BUILDING THREE, SUITE 100 AUSTIN, TEXAS 78738 (Filed With SEC on August 28, 2017)
- Exhibit 10.1 (Filed With SEC on April 6, 2015)
- Exhibit 10.1 (Filed With SEC on January 13, 2015)
- Exhibit 10.1 (Filed With SEC on August 21, 2014)
- Exhibit 10.1 (Filed With SEC on December 17, 2013)
- STOCKHOLDERS AGREEMENT (Filed With SEC on May 14, 2013)
- DEFINITIONS FOR PURPOSES OF THIS OFFER LETTER (Filed With SEC on September 26, 2011)
- AMENDMENT NO.5 TO STRATEGIC ALLIANCE AGREEMENT (Filed With SEC on May 10, 2011)
- AMENDMENT NO. 4 TO STRATEGIC ALLIANCE AGREEMENT (Filed With SEC on November 12, 2010)
- VERMILLION, INC. (Filed With SEC on February 12, 2010)
- AMENDMENT TO STRATEGIC ALLIANCE AGREEMENT (Filed With SEC on October 21, 2009)
- $1,500,000.00 (Filed With SEC on October 21, 2009)
- Entry Into a Material Definitive Agreement (Filed With SEC on December 17, 2008)
- Exhibit No (Filed With SEC on November 19, 2008)
- Entry Into a Material Definitive Agreement (Filed With SEC on August 29, 2008)
- Entry into a Material Definitive Agreement (Filed With SEC on August 29, 2008)
- Oppenheimer & Co. Inc. 125 Broad Street 16th Floor New York, NY 10014 Member of All Principal Exchanges (Filed With SEC on November 27, 2007)
- Current assets (Filed With SEC on November 14, 2007)
- Current assets (Filed With SEC on November 14, 2007)
- VERMILLION, INC. THIRD AMENDMENT TO RIGHTS AGREEMENT (Filed With SEC on September 12, 2007)
- EXHIBIT NO (Filed With SEC on August 29, 2007)
- EXHIBIT NO (Filed With SEC on July 12, 2007)
- CIPHERGEN BIOSYSTEMS, INC. (Filed With SEC on November 21, 2006)
- Pro Forma Financial Information (Filed With SEC on November 14, 2006)
- Dated 22September 2005 (Filed With SEC on March 17, 2006)
- EMPLOYMENTAGREEMENT (Filed With SEC on December 21, 2005)
- CIPHERGENBIOSYSTEMS, INC. SECONDAMENDMENT TO RIGHTS AGREEMENT (Filed With SEC on October 4, 2005)
- PATENTSECURITY AGREEMENT (Filed With SEC on July 28, 2005)
- CIPHERGENBIOSYSTEMS, INC. STOCKPURCHASE AGREEMENT (Filed With SEC on July 28, 2005)
- STRATEGIC ALLIANCE AGREEMENT BETWEEN QUESTDIAGNOSTICS INCORPORATED AND CIPHERGENBIOSYSTEMS, INC. DATED: JULY 22, 2005 (Filed With SEC on July 28, 2005)
- CIPHERGENBIOSYSTEMS, INC. AMENDMENTTO RIGHTS AGREEMENT (Filed With SEC on July 28, 2005)
- VOLUMEPURCHASE AGREEMENT (PURCHASER SIDE) (Filed With SEC on March 22, 2005)
- SUMMARY PLAN DESCRIPTION Ciphergen Biosystems Inc. 401(k) Plan (Filed With SEC on March 22, 2005)
